Hailing Lu

3.2k total citations
63 papers, 2.4k citations indexed

About

Hailing Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hailing Lu has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 27 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Hailing Lu's work include Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (12 papers) and Immune Response and Inflammation (11 papers). Hailing Lu is often cited by papers focused on Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (12 papers) and Immune Response and Inflammation (11 papers). Hailing Lu collaborates with scholars based in United States, Italy and United Kingdom. Hailing Lu's co-authors include Mary L. Disis, Ekram Gad, Vivian Goodell, Abbi L. Engel, Yushe Dang, Gregory E. Holt, Keith L. Knutson, Yi Yang, Lucio G. Costa and Marina Guizzetti and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Hailing Lu

61 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hailing Lu 1.4k 977 772 249 169 63 2.4k
Adam E. Snook 757 0.5× 985 1.0× 799 1.0× 324 1.3× 117 0.7× 118 2.4k
Yongchang Qiu 874 0.6× 653 0.7× 1.4k 1.8× 95 0.4× 146 0.9× 58 3.0k
Liping Wang 1.4k 1.0× 716 0.7× 1.2k 1.6× 342 1.4× 179 1.1× 86 3.5k
Haiyan Sun 675 0.5× 573 0.6× 1.2k 1.6× 103 0.4× 118 0.7× 71 2.5k
Hiro Wakasugi 1.7k 1.2× 1.1k 1.1× 1.5k 1.9× 241 1.0× 158 0.9× 90 3.6k
Francesca Spadaro 1.2k 0.9× 608 0.6× 1.4k 1.9× 210 0.8× 247 1.5× 65 2.9k
Charles S. Tannenbaum 1.8k 1.3× 1.2k 1.2× 976 1.3× 84 0.3× 286 1.7× 59 2.9k
Holger Bang 891 0.6× 516 0.5× 1.7k 2.2× 562 2.3× 122 0.7× 65 3.3k
Yoshiyuki Takahara 961 0.7× 679 0.7× 815 1.1× 252 1.0× 120 0.7× 28 2.4k

Countries citing papers authored by Hailing Lu

Since Specialization
Citations

This map shows the geographic impact of Hailing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailing Lu more than expected).

Fields of papers citing papers by Hailing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailing Lu. The network helps show where Hailing Lu may publish in the future.

Co-authorship network of co-authors of Hailing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hailing Lu. A scholar is included among the top collaborators of Hailing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailing Lu. Hailing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Sylvia M., Omid Hamid, Robert M. Jotte, et al.. (2024). Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1–Pretreated Metastatic Non–Small Cell Lung Cancer and Metastatic Cutaneous Melanoma. Clinical Cancer Research. 31(5). 848–859. 1 indexed citations
2.
Pusztai, Lajos, Hailing Lu, Anne Große-Wilde, et al.. (2020). 323 Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients. Regular and Young Investigator Award Abstracts. A198–A199. 3 indexed citations
3.
Somaiah, Neeta, Matthew S. Block, Joseph W. Kim, et al.. (2019). First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1. Clinical Cancer Research. 25(19). 5808–5817. 71 indexed citations
4.
Stanton, Sasha E., et al.. (2019). Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets. Vaccine. 37(27). 3552–3561. 16 indexed citations
5.
Bhatia, Shailender, Natalie J. Miller, Hailing Lu, et al.. (2018). Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma. Clinical Cancer Research. 25(4). 1185–1195. 103 indexed citations
6.
Chawla, Sant P., Brian A. Van Tine, Seth M. Pollack, et al.. (2017). A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+ soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival. Annals of Oncology. 28. v523–v523. 12 indexed citations
7.
Standish, Leanna J., et al.. (2014). The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan. Journal of Natural Medicines. 69(2). 198–208. 14 indexed citations
8.
Engel, Abbi L., Ekram Gad, Yi Yang, et al.. (2013). Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant. Immunobiology. 218(12). 1468–1476. 28 indexed citations
9.
Lu, Hailing, Gregory N. Dietsch, Yi Yang, et al.. (2011). VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC. Clinical Cancer Research. 18(2). 499–509. 134 indexed citations
10.
Lu, Hailing, Yi Yang, Ekram Gad, et al.. (2011). TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy. Clinical Cancer Research. 17(21). 6742–6753. 71 indexed citations
11.
Engel, Abbi L., Gregory E. Holt, & Hailing Lu. (2011). The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system. Expert Review of Clinical Pharmacology. 4(2). 275–289. 163 indexed citations
12.
Wenner, Cynthia A., Mark R. Martzen, Hailing Lu, et al.. (2011). Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer. International Journal of Oncology. 40(4). 905–913. 19 indexed citations
13.
Lu, Hailing, Yi Yang, Ekram Gad, et al.. (2010). Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells. Clinical Cancer Research. 17(1). 67–76. 125 indexed citations
14.
Lu, Hailing, Wolfgang Wagner, Ekram Gad, et al.. (2010). Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade. The Journal of Immunology. 184(9). 5360–5367. 64 indexed citations
15.
Disis, Mary L., Danelle R. Wallace, Theodore A. Gooley, et al.. (2009). Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer. Journal of Clinical Oncology. 27(28). 4685–4692. 224 indexed citations
16.
Lu, Hailing, Vivian Goodell, & Mary L. Disis. (2007). Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer. Expert Opinion on Therapeutic Targets. 11(2). 235–244. 23 indexed citations
17.
Lu, Hailing, Keith L. Knutson, Ekram Gad, & Mary L. Disis. (2006). The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens. Cancer Research. 66(19). 9754–9761. 49 indexed citations
18.
Knutson, Keith L., Yushe Dang, Hailing Lu, et al.. (2006). IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu -Transgenic Mice. The Journal of Immunology. 177(1). 84–91. 99 indexed citations
19.
Lu, Hailing, Zhuo Zhao, Tomáš Kalina, Hans‐Peter Kiem, & Jan Storek. (2005). Interleukin-7 improves reconstitution of antiviral CD4 T cells. Biology of Blood and Marrow Transplantation. 11(2). 53–54. 2 indexed citations
20.
Yokota, Hiroki, Frank Johnson, Hailing Lu, et al.. (1997). A New Method for Straightening DNA Molecules for Optical Restriction Mapping. Nucleic Acids Research. 25(5). 1064–1070. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam E. Snook Breakdown of academic impact, for papers by Yongchang Qiu Breakdown of academic impact, for papers by Liping Wang Breakdown of academic impact, for papers by Haiyan Sun Breakdown of academic impact, for papers by Hiro Wakasugi Breakdown of academic impact, for papers by Francesca Spadaro Breakdown of academic impact, for papers by Charles S. Tannenbaum Breakdown of academic impact, for papers by Holger Bang Breakdown of academic impact, for papers by Yoshiyuki Takahara
Rankless by CCL
2026